ATE461452T1 - Verfahren zum nachweis von menschlichem parvovirus-antigen - Google Patents
Verfahren zum nachweis von menschlichem parvovirus-antigenInfo
- Publication number
- ATE461452T1 ATE461452T1 AT06821550T AT06821550T ATE461452T1 AT E461452 T1 ATE461452 T1 AT E461452T1 AT 06821550 T AT06821550 T AT 06821550T AT 06821550 T AT06821550 T AT 06821550T AT E461452 T1 ATE461452 T1 AT E461452T1
- Authority
- AT
- Austria
- Prior art keywords
- antigen
- detecting human
- human parvovirus
- measurement
- parvovirus antigen
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title abstract 4
- 102000036639 antigens Human genes 0.000 title abstract 4
- 108091007433 antigens Proteins 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 241000484121 Human parvovirus Species 0.000 title abstract 2
- 239000000872 buffer Substances 0.000 abstract 2
- 238000005259 measurement Methods 0.000 abstract 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 241000121268 Erythroparvovirus Species 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 239000010836 blood and blood product Substances 0.000 abstract 1
- 229940125691 blood product Drugs 0.000 abstract 1
- 238000003018 immunoassay Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 239000001509 sodium citrate Substances 0.000 abstract 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 abstract 1
- 229940038773 trisodium citrate Drugs 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G01N2333/015—Parvoviridae, e.g. feline panleukopenia virus, human Parvovirus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IE2006/000141 WO2008072216A1 (en) | 2006-12-15 | 2006-12-15 | A method for detecting human parvovirus antigen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE461452T1 true ATE461452T1 (de) | 2010-04-15 |
Family
ID=37903609
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06821550T ATE461452T1 (de) | 2006-12-15 | 2006-12-15 | Verfahren zum nachweis von menschlichem parvovirus-antigen |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20100105069A1 (de) |
| EP (1) | EP2095126B1 (de) |
| JP (1) | JP2010513865A (de) |
| AT (1) | ATE461452T1 (de) |
| CA (1) | CA2671474C (de) |
| DE (1) | DE602006013053D1 (de) |
| DK (1) | DK2095126T3 (de) |
| WO (1) | WO2008072216A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2012222888A1 (en) * | 2011-03-03 | 2013-09-26 | Novartis Ag | Method for detecting parvovirus antigen |
| EP3130922A1 (de) * | 2015-08-11 | 2017-02-15 | Roche Diagnostics GmbH | Alkalische vorbehandlung von parvoviren für immunoassays |
| WO2017065261A1 (ja) * | 2015-10-15 | 2017-04-20 | 富士レビオ株式会社 | ヒトパルボウイルスｂ１９抗原および抗体の同時検出方法及びキット |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2755817B2 (ja) * | 1988-11-14 | 1998-05-25 | アメリカ合衆国 | パルボウイルスキャプシド |
| JPH0910000A (ja) * | 1995-06-26 | 1997-01-14 | Nippon Sekijiyuujishiya | ヒトパルボウイルスの検出方法及びそのための試薬 |
| JP4449171B2 (ja) * | 2000-06-05 | 2010-04-14 | 富士レビオ株式会社 | ヒトパルボウイルスｂ１９抗原の免疫測定方法 |
| JP2003066047A (ja) * | 2001-06-14 | 2003-03-05 | Matsushita Electric Ind Co Ltd | 免疫反応測定方法及びそれに用いる免疫反応測定用試薬 |
-
2006
- 2006-12-15 EP EP06821550A patent/EP2095126B1/de not_active Not-in-force
- 2006-12-15 AT AT06821550T patent/ATE461452T1/de not_active IP Right Cessation
- 2006-12-15 CA CA2671474A patent/CA2671474C/en not_active Expired - Fee Related
- 2006-12-15 WO PCT/IE2006/000141 patent/WO2008072216A1/en not_active Ceased
- 2006-12-15 DE DE602006013053T patent/DE602006013053D1/de active Active
- 2006-12-15 JP JP2009540963A patent/JP2010513865A/ja active Pending
- 2006-12-15 DK DK06821550.8T patent/DK2095126T3/da active
- 2006-12-15 US US12/519,063 patent/US20100105069A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2095126B1 (de) | 2010-03-17 |
| DE602006013053D1 (de) | 2010-04-29 |
| CA2671474A1 (en) | 2008-06-19 |
| CA2671474C (en) | 2012-09-04 |
| DK2095126T3 (da) | 2010-05-10 |
| EP2095126A1 (de) | 2009-09-02 |
| JP2010513865A (ja) | 2010-04-30 |
| WO2008072216A1 (en) | 2008-06-19 |
| US20100105069A1 (en) | 2010-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2013009703A3 (en) | Antibodies, kit and method for detecting amyloid beta oligomers | |
| TW200512457A (en) | Method of diagnosing SARS corona virus infection | |
| DE60228557D1 (de) | Candida-nachweis | |
| EP3750916A3 (de) | Monoklonale antikörper gegen das denguevirus-ns1-protein | |
| DE602004026014D1 (de) | Verfahren zum Nachweis von medizinisch relevanten Zuständen in gelösten LBC-Proben | |
| ATE501280T1 (de) | Verfahren zum nachweis eines analyten in einer biologischen matrix | |
| DE60326336D1 (de) | Vorrichtung und verfahren um gleichzeitig verschiedene antikörper und antigene nachzuweisen in klinischen, nahrungsmittel- und umwelt-proben | |
| DE602007007775D1 (de) | Reagenz für hämoglobinabbau | |
| DE60315715D1 (de) | Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs | |
| DE60325382D1 (de) | Verfahren zur diagnose von gebärmutterhalskrebs | |
| DE60331857D1 (de) | Markerproteine zur diagnose einer lebererkrankung und verfahren zur diagnose einer lebererkrankung damit | |
| ATE420360T1 (de) | Verfahren zur unterscheidung von morbus crohn von ulzerativer colitis und anderen magen-darm- erkrankungen durch nachweis des vorhandenseins von fäkalen antikörpern gegen saccharomyces cerevisiae | |
| WO2011109112A3 (en) | Method of detecting tau protein and tau fragments in serum | |
| ATE514948T1 (de) | In vitro verfahren zur diagnose von neurodegenerativen erkrankungen | |
| DE602006021038D1 (de) | Verfahren zur diagnose eines ovarialkarzinoms | |
| ATE461452T1 (de) | Verfahren zum nachweis von menschlichem parvovirus-antigen | |
| FR2930036B1 (fr) | Procede de diagnostic d'une hypertension arterielle pulmonaire. | |
| WO2018172337A8 (en) | IMMUNOASSAY FOR THE DETECTION OF ZIKA VIRUS INFECTION | |
| ATE489632T1 (de) | Antigennachweis | |
| ATE475098T1 (de) | Verfahren zur messung von plasmaspiegeln von pentraxin ptx3 | |
| DE50212790D1 (de) | Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper | |
| FR2894675B1 (fr) | Distinction des meningites bacteriennes et virales | |
| WO2009016734A1 (ja) | 軽度認知機能障害の検定方法 | |
| DE602006015221D1 (de) | Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression | |
| ATE443871T1 (de) | Test zum nachweis von pathologischen prionen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |